Myriad Genetics Inc (MYGN)
17.98
-0.65
(-3.49%)
USD |
NASDAQ |
Apr 25, 16:00
18.00
+0.02
(+0.11%)
Pre-Market: 20:00
Myriad Genetics Price to Book Value: 2.063 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 2.063 |
| April 24, 2024 | 2.138 |
| April 23, 2024 | 2.134 |
| April 22, 2024 | 2.122 |
| April 19, 2024 | 2.123 |
| April 18, 2024 | 2.124 |
| April 17, 2024 | 2.139 |
| April 16, 2024 | 2.171 |
| April 15, 2024 | 2.200 |
| April 12, 2024 | 2.243 |
| April 11, 2024 | 2.352 |
| April 10, 2024 | 2.325 |
| April 09, 2024 | 2.396 |
| April 08, 2024 | 2.334 |
| April 05, 2024 | 2.325 |
| April 04, 2024 | 2.320 |
| April 03, 2024 | 2.330 |
| April 02, 2024 | 2.295 |
| April 01, 2024 | 2.460 |
| March 28, 2024 | 2.446 |
| March 27, 2024 | 2.456 |
| March 26, 2024 | 2.466 |
| March 25, 2024 | 2.522 |
| March 22, 2024 | 2.552 |
| March 21, 2024 | 2.559 |
| Date | Value |
|---|---|
| March 20, 2024 | 2.552 |
| March 19, 2024 | 2.479 |
| March 18, 2024 | 2.482 |
| March 15, 2024 | 2.428 |
| March 14, 2024 | 2.446 |
| March 13, 2024 | 2.471 |
| March 12, 2024 | 2.475 |
| March 11, 2024 | 2.591 |
| March 08, 2024 | 2.595 |
| March 07, 2024 | 2.618 |
| March 06, 2024 | 2.632 |
| March 05, 2024 | 2.551 |
| March 04, 2024 | 2.521 |
| March 01, 2024 | 2.545 |
| February 29, 2024 | 2.402 |
| February 28, 2024 | 2.480 |
| February 27, 2024 | 2.697 |
| February 26, 2024 | 2.631 |
| February 23, 2024 | 2.607 |
| February 22, 2024 | 2.651 |
| February 21, 2024 | 2.629 |
| February 20, 2024 | 2.698 |
| February 16, 2024 | 2.669 |
| February 15, 2024 | 2.708 |
| February 14, 2024 | 2.687 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6768
Minimum
Mar 18 2020
3.178
Maximum
Aug 02 2019
1.956
Average
1.960
Median
May 22 2023
Price to Book Value Benchmarks
| Stryker Corp | 6.895 |
| Haemonetics Corp | 4.719 |
| Perspective Therapeutics Inc | 12.49 |
| Electromed Inc | 3.451 |
| Xtant Medical Holdings Inc | 2.286 |
Price to Book Value Related Metrics
| PS Ratio | 1.977 |
| PEG Ratio | -0.0432 |
| Price | 17.98 |
| Earnings Yield | -17.80% |
| Market Cap | 1.616B |
| PEGY Ratio | -0.0432 |